Ireland· IE-PA-EU/1/00/152/006
Infanrix hexa
A bacterial and viral vaccines, combined product containing filamentous haemagglutinin + polysaccharide-k + diphtheria toxoid + haemophilus influenzae, registered in Ireland by GlaxoSmithKline Biologicals S.A.. The same ATC class is registered in 2 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Filamentous haemagglutinin + polysaccharide-k + diphtheria toxoid + haemophilus influenzae is registered in 2 of 19 countries.
Countries holding a registration under ATC J07CA (bacterial and viral vaccines, combined), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
Filamentous haemagglutinin + polysaccharide-k + diphtheria toxoid + haemophilus influenzae · ATC J07CA
2 / 19 countries
- Denmark
- Ireland
The record
At a glance
HPRA (Ireland)- Active substance
- Filamentous haemagglutinin + Polysaccharide-k + Diphtheria toxoid + Haemophilus influenzae
- Manufacturer
- GlaxoSmithKline Biologicals S.A.
- Country
- Ireland (IE)
- ATC code
- J07CA
- ATC class
- Bacterial and viral vaccines, combined
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/00/152/006
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07CA
Bacterial and viral vaccines, combined, as other registers publish it.
- DenmarkHexavacAventis Pasteur MSD SNC
- IrelandInfanrix hexaGlaxoSmithKline Biologicals S.A.
- IrelandInfanrix hexaGlaxoSmithKline Biologicals S.A.
- IrelandInfanrix hexaGlaxoSmithKline Biologicals S.A.
- IrelandInfanrix hexaGlaxoSmithKline Biologicals S.A.
- IrelandInfanrix hexaGlaxoSmithKline Biologicals S.A.
- IrelandInfanrix hexaGlaxoSmithKline Biologicals S.A.
- IrelandInfanrix hexaGlaxoSmithKline Biologicals S.A.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/da6a3696-0119-4f6c-87fb-8a52af1dbf05 GET /v1/drugs/da6a3696-0119-4f6c-87fb-8a52af1dbf05?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder and suspension for suspension for injection",
"routes": null,
"source": "hpra",
"atc_all": [
"J07CA"
],
"strength": null,
"pa_number": "EU/1/00/152/006",
"substances": [
"Filamentous haemagglutinin",
"Polysaccharide-k",
"Diphtheria toxoid",
"Haemophilus influenzae",
"Tetanus toxoid",
"Pertactin",
"Pertussis toxoid",
"Hbs ag"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Marketed",
"authorised_at": null,
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about filamentous haemagglutinin + polysaccharide-k + diphtheria toxoid + haemophilus influenzae.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.